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Abstract
Esophagic Intramural Hematoma is an uncommon clinical condition, with a prognosis which is
essentially benign. On most cases, a predisposing or precipitating factor may be seen, with the most
common ones being the history of esophagic instrumentation, food impactations and
thrombocytopenia. In the following manuscript, the authors present the case of a 54-years-old male
with history of valve replacement surgery, who was treated at the Clinica Cardiovascular (Medellin,
Colombia), with a clinical case of Intramural Esophagic Hematoma that was later confirmed to be
due to a Coumarinic overanticoagulation. On this case, it is evidenced that Intramural Esophagic
Hematoma is an unrecognized complication of Courmarinic anticoagulation therapy.
Introduction
IEH was described for the first time by Williams in
1957[1]. It is an very uncommon clinical entity[2], but
fortunately its prognosis remains essentially benign with
only very few patients requiring an invasive therapeutic
approach[3]. Nevertheless, a high level of suspicion is
required in order to make an accurate diagnosis due to the
unspecific nature of its clinical presentation.
In the present article, we describe the case of a 54 year old
male individual who had undergone aortic mechanical
valve replacement surgery in our institution, and as a
result needed lifetime anticoagulation therapy with warfa-
rin. He presented to us approximately two and a half
months after the procedure with symptoms of dysphagia
and was eventually diagnosed with a symptomatic IEH
secondary to supratherapeutic anticoagulation despite
usual doses of warfarin and strict adherence to recom-
mendations.
Case presentation
A 54 year old male underwent coronary artery bypass graft
(CABG) surgery and replacement of his native aortic valve
for a mechanical prosthesis for treatment for severe aortic
insufficiency at our institution. His postoperative course
was uneventful and after initiation of warfarin therapy
and careful monitoring of his Intrenational Normatized
Ratio (INR) to ensure therapeutic anticoagulation (target
INR 2.5-3.5), the patient was discharged home to con-
tinue ambulatory warfarin therapy at a dose of 5 mg daily.
48 days after surgery, the patient was readmitted to our
institution because of severe pain in his left flank. During
this hospitalization he was diagnosed with a large splenic
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hematoma and an associated massive hemoperitoneum,
his INR at admission was 9.4. He was initially managed
conservatively, but after two days it was decided that the
patient required invasive treatment with splenectomy and
drainage of the hemoperitoneum because of a drop of 4
gr/dl in hemoblobin value within a day. At discharge the
warafrin dose was readjusted to 2.5 mg with an INR of 2.8.
His second postoperative course was uncomplicated until
25 days later (73 days after the initial valve replacement
surgery), when he presented to our Emergency Depart-
ment with a 24 hour history of frank dysphagia and asso-
ciated dyspepsia and flatulence.
Upon initial evaluation he was noted to be hemodynam-
ically stable with a blood pressure of 122/76 mmHg and
a heart rate of 65 beats per minute and he was on beta
blocker therapy. Upon further evaluation, a mildly bleed-
ing, vesicular lesion has found on his right oropharynx;
there was not tenderness to neck palpation or regional
lymphadenopathy. The patient denied a history of obvi-
ous spontaneous bleeding or painful swallowing. Labora-
tory tests ordered at that time revealed supratherapeutic
anticoagulation with an INR "infinite", and a hemoglobin
and hematocrit levels of 10.1 gr/dL and 31,4% respec-
tively (Table 1. Other laboratory tests included the follow-
ing: Leukocytes 11.610, Neutrophil 76%, serum
creatinine 0,9 mg/dL, blood ureic nitrogen (BUN) 14 mg/
dL. Warfarin therapy was immediately discontinued in an
attempt to normalize his clotting parameters.
The initial differential diagnosis included acute pharyngi-
tis and azitromycin was prescribed. However, due to a per-
sistent complaint of dysphagia, a diagnostic upper
endoscopy (EGD) was performed. The EGD revealed a
pale distal mucosa and the presence of a large submucosal
Table 1: Relevant INR values during hospitalization.
Day of Hosp. INR Comments
1 "Infinite" Initial INR; longer than 120. Warfarin was suspended.
2 "Infinite" Longer than 120. Patient develops hematuria. SDE diagnoses IEH.
3 "Infinite" Longer than 120. 4 units of FFP are given.
4 6.2 3 units of FFP are given.
5 5.6 4 units of FFP are given.
6 7.0 -
7 7.7 First dose of Vitamin K 10 mg is administered.
8 1.5 Hematuria resolves.
10 2.4 -
12 3.6 Second dose of Vitamin K 10 mg is administered.
16 1.9 -
19 2.2 -
21 1.8 -
23 1.5 Warfarin 2.5 mg oral is started again.
26 2.0 Normal SDE.
29 2.7 -
31 2.5 Patient is discharged.
INR = International Normalized Ratio. SDE = Superior Digestive Endoscopy. IEH = Intramural Esophagic Hematoma. FFP = Fresh Frozen Plasma.Cases Journal 2009, 2:9368 http://www.casesjournal.com/content/2/1/9368
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ecchymosis/hematoma that extended to the level of the
cardias. These findings were consistent with an IEH (Fig-
ure 1).
During the course of his hospitalization, in addition to his
diagnosis of IEH, our patient had other clinical and labo-
ratory manifestations that reflected his supratherapeutic
anticoagulation status, including macroscopic hematuria
and severe worsening anemia. He received multiple trans-
fusions of fresh frozen plasma (FFP) and packed red
blood cells (PRBC), as well as administration of vitamin
K. His coagulation parameters eventually returned to nor-
mal and after an observation period of ten days, anticoag-
ulation with warfarin was restarted with careful serial
monitoring of his INR, remaining within therapeutic level
throughout the rest of his hospital stay and without any
bleeding complications.
Five days before discharge from the hospital, an EGD was
performed, which showed no evidence of the findings of
the previous EGD, performed 24 days earlier, suggesting a
spontaneous resolution of the IEH (Figure 2). After dis-
charge, the patient had a close clinical follow up, and his
INR was monitored at frequent intervals. His symptoms
improved completely and he has had no further clinical or
laboratory evidence of coumarinic toxicity.
Discussion
IEH is an uncommon, although well documented cause of
acute thoracic pain[4], often associated with additional
digestive symptoms such as dysphagia and hemateme-
sis[5,6]. The condition has been described to occur spon-
taneously as consequence of an abrupt rise on
intraesophageal pressure[7,8], although in most cases, a
precipitating event may be found, the most common
being a history of previous esophageal instrumenta-
tion[5].
According to Martínez et al[5], the most common clinical
manifestation among patients with IEH is acute thoracic
pain in 87% of cases, followed by hematemesis, dys-
phagia and pain while swallowing in 70%, 26% and 26%
of cases respectively. It is important to mention that in up
to 60% of cases there is a history of a predisposing factor,
most commonly a history of esophageal instrumentation,
food impaction and bleeding dyscrasias like thrombocy-
topenia[5,9,10]. Well documented cases of IEH secondary
to anticoagulation therapy with warfarin are sparse in
worldwide literature, which makes the present report all
the more relevant[7,11,12].
The case we have just presented is, to the author's knowl-
edge, the first reported case of IEH secondary to cou-
marinic anticoagulation reported from a Latin American
institution and one of the few reported from around the
world[7,11,12]. Coumarinics, in particular warfarin, are
medicines prescribed frequently for a myriad of medical
conditions and in all sorts of patients. The practicing phy-
sician should be aware of the potential complications of
anticoagulation, including IEH, a condition that albeit
uncommon, may carry a lethality of up to 7-9% in
patients with other associated commorbidities[7].
In this case, it is fairly clear that this rare complication was
the result of a supratherapeutic level of anticoagulation
with warfarin, medication which was clinically indicated
after the patient's CABG and valve replacement surgery.
Upon presentation to our emergency department, this
individual had an INR reported as >120 seconds, other-
wise known as an "infinite INR", reflecting the labora-
tory's inability to accurately calculate it. Although there
was no history of immediate active bleeding prior to pres-
entation, our patient had recently been hospitalized with
a splenic hematoma and hemoperitoneum that required
surgical intervention and drainage, and at this time his
INR level was found to be elevated above the therapeutic
range. This severe clotting dysfunction may be enough to
justify spontaneous bleeding on multiple sites of the
human body, including those that may not be evident to
a careful physical examination.
Superior Digestive Endoscopy showing the presence of great  submucosal ecchymosis compatible with Intramural  Esophagic Hematoma Figure 1
Superior Digestive Endoscopy showing the presence 
of great submucosal ecchymosis compatible with 
Intramural Esophagic Hematoma. Courtesy of William 
Darío Lopera Lotero, MD.
Superior Digestive Endoscopy showing the absence of sub- mucosal ecchymosis, compatible with spontaneous resolu- tion of Esophagic Hematoma Figure 2
Superior Digestive Endoscopy showing the absence 
of submucosal ecchymosis, compatible with sponta-
neous resolution of Esophagic Hematoma. Courtesy of 
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This clinical case also highlights the benign course of
IEH[3,4,13], as the condition resolved spontaneously
once clotting mechanisms are normalized. It must be
stressed however that its benign course is dependent on
the consideration of this entity in the differential diagno-
sis and work up of a patient who presents with symptoms
and signs compatible with IEH and who has a predispos-
ing condition making him prone to developing it, hence
stressing the importance of this report.
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